Amalia S. Magaret
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amalia S. Magaret has a total of 307 co-authors. Here are the top co-authors by number of shared publications:
- Anna Wald
Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington , Seattle, WA
9 shared publications - Christine Johnston
University of Washington
6 shared publications - Emily Maria Godfrey
Professor of Family Medicine and Obstetrics and Gynecology, University of Washington, Departments of Family Medicine and Obstetrics and Gynecology;1959 N.E. Pacific Street, Box 356390, Seattle, WA 98195-6390
5 shared publications - Alexander Greninger
Department of Laboratory Medicine and Pathology, University of Washington Medical Center
4 shared publications Nicole Mayer-Hamblett
Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children’s Hospital, Seattle, WA, USA
4 shared publicationsAnna Wald
Departments of Medicine, Epidemiology and Laboratory Medicine, University of Washington, Seattle, Washington, USA
3 shared publications
Latest Publications
- 19 April 2026
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 25 (3) , 482-488
Association of CFRD development among females with CF who use hormonal contraception
- 19 April 2026
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 25 (3) , 482-488
Association of CFRD development among females with CF who use hormonal contraception
- 27 March 2026
- Published by Elsevier in Contraception
- Vol. 161, 111454
Liver cirrhosis among females with cystic fibrosis using hormonal contraception
- 27 March 2026
- Published by Elsevier in Contraception
- Vol. 161, 111454
Liver cirrhosis among females with cystic fibrosis using hormonal contraception
- 26 May 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 691-697
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis
- 26 May 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 691-697
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis
- Open Access
- 12 April 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 684-690
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study
- 12 April 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 684-690
Open AccessTrial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study
- 21 March 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 425-426
Response to editorial
- 21 March 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 425-426
Response to editorial
- 22 January 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (3) , 491-497
Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers
- 22 January 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (3) , 491-497
Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers
- 29 November 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 236, 107890
Need for re-assessment of impact of repeated pregnancy on lung health in cystic fibrosis
- 29 November 2024
- Published by Elsevier in Respiratory Medicine
- Vol. 236, 107890
Need for re-assessment of impact of repeated pregnancy on lung health in cystic fibrosis
- Open Access
- 5 October 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 42, 101378
Baseline-dependent improvement in CF studies, plausibility of bias
- 5 October 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 42, 101378
Open AccessBaseline-dependent improvement in CF studies, plausibility of bias
- 14 August 2024
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (5) , 943-946
Impact of day-to-day variation in FEV1 on measures of change: A conceptual description
- 14 August 2024
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (5) , 943-946
Impact of day-to-day variation in FEV1 on measures of change: A conceptual description
- 3 August 2024
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 263-270
Association of race and ethnicity with the development of cystic fibrosis-related diabetes
- 3 August 2024
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 263-270
Association of race and ethnicity with the development of cystic fibrosis-related diabetes